Structures by: Jackson W. R.
Total: 14
C54H54Bi2O18
C54H54Bi2O18
Journal of the Chemical Society, Dalton Transactions (2002) 24 4634
a=10.5533(9)Å b=11.3356(10)Å c=12.3665(10)Å
α=87.561(2)° β=71.084(2)° γ=67.110(2)°
C6H13BiO2S2
C6H13BiO2S2
Journal of the Chemical Society, Dalton Transactions (2002) 24 4634
a=9.4779(8)Å b=9.8471(8)Å c=21.152(2)Å
α=90.00000° β=90.00000° γ=90.00000°
C18H28N2
C18H28N2
Acta Crystallographica Section E (2003) 59, 8 o1163-o1164
a=8.5423(2)Å b=8.8892(2)Å c=10.6486(2)Å
α=90° β=90° γ=90°
C21H25N1O4
C21H25N1O4
Acta Crystallographica Section E (2001) 57, 10 o983-o984
a=16.8250(10)Å b=13.5500(10)Å c=8.1730(10)Å
α=90° β=95.020(10)° γ=90°
6,8-dimethyl-2-(4-methoxyphenyl)imidazo[1,2-a]1,8-naphthyridine.
C19H17N3O
Acta Crystallographica Section C (1996) 52, 9 2236-2239
a=8.041(1)Å b=13.567(1)Å c=15.030(1)Å
α=93.520(1)° β=97.320(1)° γ=105.93(1)°
6-methyl-2-(4-methylphenyl)-8-trifluoromethylimidazo[1,2-a][1,8] naphthyridine.
C19H14F3N3
Acta Crystallographica Section C (1996) 52, 9 2231-2236
a=9.092(1)Å b=9.849(1)Å c=10.428(1)Å
α=68.90(1)° β=69.39(1)° γ=72.67(1)°
1-diethylaminomethyl-6,8-dimethyl-2-(4-methylphenyl)imidazo[1,2-a][1,8] naphthyridine.
C24H28N4
Acta Crystallographica Section C (1996) 52, 9 2239-2243
a=9.387(1)Å b=10.173(2)Å c=11.6980(1)Å
α=110.36(1)° β=91.83(1)° γ=103.34(1)°
2-(4-methoxyphenyl)-6-methyl-8-phenylimidazo[1,2-a][1,8]naphthyridine.
C24H19N3O
Acta Crystallographica Section C (1996) 52, 9 2236-2239
a=8.435(1)Å b=7.146(1)Å c=31.823(3)Å
α=90.00° β=92.00(1)° γ=90.00°
1-diethylaminomethyl-6,8-dimethyl-2-(4-methoxyphenyl)imidazo[1,2-a][1,8] naphthyridine.
C24H28N4O
Acta Crystallographica Section C (1996) 52, 9 2239-2243
a=7.358(1)Å b=10.641(1)Å c=13.586(1)Å
α=96.55(1)° β=95.64(1)° γ=98.11(1)°
2-(4-bromophenyl)-1-diethylaminomethyl-6,8-dimethylimidazo[1,2-a][1,8] naphthyridine.
C23H25BrN4
Acta Crystallographica Section C (1996) 52, 9 2239-2243
a=12.134(1)Å b=12.833(2)Å c=15.250(2)Å
α=113.98(1)° β=91.33(1)° γ=105.68(1)°
2-(4-chlorophenyl)-6-methyl-8-trifluoromethylimidazo[1,2-a][1,8] naphthyridine.
C18H11ClF3N3
Acta Crystallographica Section C (1996) 52, 9 2231-2236
a=8.422(2)Å b=9.042(1)Å c=12.859(3)Å
α=70.43(2)° β=89.09(2)° γ=62.25(1)°
2-(4-bromophenyl)-6-methyl-8-trifluoromethylimidazo[1,2,-a][1,8] naphthyridine.
C18H11BrF3N3
Acta Crystallographica Section C (1996) 52, 9 2231-2236
a=8.557(1)Å b=8.954(1)Å c=12.957(1)Å
α=70.12(1)° β=72.27(1)° γ=63.19(1)°
2-(3,4-difluorophenyl)-6-methyl-8-trifluoromethylimidazo[1,2-a][1,8] naphthyridine.
C18H10F5N3
Acta Crystallographica Section C (1996) 52, 9 2231-2236
a=7.916(7)Å b=8.454(6)Å c=12.838(9)Å
α=73.64(2)° β=87.62(6)° γ=70.08(7)°
C15H19N3O4
C15H19N3O4
Zeitschrift für Kristallographie - New Crystal Structures (2002) 217, 1 91-93
a=16.54(1)Å b=9.392(8)Å c=21.39(1)Å
α=90° β=107.92(6)° γ=90°